These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 32381748)

  • 21. Timed instrumental activities of daily living in multiple sclerosis: The test of everyday cognitive ability (TECA).
    Charvet LE; Shaw MT; Sherman K; Haas S; Krupp LB
    Mult Scler Relat Disord; 2018 Jul; 23():69-73. PubMed ID: 29778936
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cognitive impairment in MS: rehabilitation approaches.
    Hämäläinen P; Rosti-Otajärvi E
    Acta Neurol Scand; 2016 Sep; 134 Suppl 200():8-13. PubMed ID: 27580900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The progress of cognitive decline in newly diagnosed MS patients.
    Hankomäki E; Multanen J; Kinnunen E; Hämäläinen P
    Acta Neurol Scand; 2014 Mar; 129(3):184-91. PubMed ID: 23773012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment options of cognitive impairment in multiple sclerosis.
    Patti F; Leone C; D'Amico E
    Neurol Sci; 2010 Nov; 31(Suppl 2):S265-9. PubMed ID: 20953811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early effective treatment may protect from cognitive decline in paediatric multiple sclerosis.
    Johnen A; Elpers C; Riepl E; Landmeyer NC; Krämer J; Polzer P; Lohmann H; Omran H; Wiendl H; Göbel K; Meuth SG
    Eur J Paediatr Neurol; 2019 Nov; 23(6):783-791. PubMed ID: 31540711
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cognitive impairment].
    Reuter F; Audoin B; Rico A; Malikova I; Ranjeva JP; Pelletier J
    Rev Neurol (Paris); 2009 Mar; 165 Suppl 4():S113-22. PubMed ID: 19361675
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Neuropsychological profile of multiple sclerosis].
    Arango-Lasprilla JC; DeLuca J; Chiaravalloti N
    Psicothema; 2007 Feb; 19(1):1-6. PubMed ID: 17295976
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Performance in daily activities, cognitive impairment and perception in multiple sclerosis patients and their caregivers.
    Fenu G; Fronza M; Lorefice L; Arru M; Coghe G; Frau J; Marrosu MG; Cocco E
    BMC Neurol; 2018 Dec; 18(1):212. PubMed ID: 30567519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduced information processing speed as primum movens for cognitive decline in MS.
    Van Schependom J; D'hooghe MB; Cleynhens K; D'hooge M; Haelewyck MC; De Keyser J; Nagels G
    Mult Scler; 2015 Jan; 21(1):83-91. PubMed ID: 25013149
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new computerised cognitive test for the detection of information processing speed impairment in multiple sclerosis.
    Ruet A; Deloire MS; Charré-Morin J; Hamel D; Brochet B
    Mult Scler; 2013 Oct; 19(12):1665-72. PubMed ID: 23459569
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Neuropsychiatric and cognitive aspectos of multiple sclerosis].
    Carrá A; Drake M
    Vertex; 2002; 13(49):217-25. PubMed ID: 12404024
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of sensory processing difficulties, cognitive impairment, and disease severity in predicting functional behavior among patients with multiple sclerosis.
    Engel-Yeger B; DeLuca J; Hake P; Goverover Y
    Disabil Rehabil; 2021 Apr; 43(8):1129-1136. PubMed ID: 31453721
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cognitive impairment in multiple sclerosis - a review of current knowledge and recent research.
    Grzegorski T; Losy J
    Rev Neurosci; 2017 Nov; 28(8):845-860. PubMed ID: 28787275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective decline in information processing in subgroups of multiple sclerosis: an 8-year longitudinal study.
    Bergendal G; Fredrikson S; Almkvist O
    Eur Neurol; 2007; 57(4):193-202. PubMed ID: 17272938
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Can we define a rehabilitation strategy for cognitive impairment in progressive multiple sclerosis? A critical appraisal.
    D'Amico E; Leone C; Hayrettin T; Patti F
    Mult Scler; 2016 Apr; 22(5):581-9. PubMed ID: 26920381
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deficits in Social Cognition: An Unveiled Signature of Multiple Sclerosis.
    Chalah MA; Ayache SS
    J Int Neuropsychol Soc; 2017 Mar; 23(3):266-286. PubMed ID: 28069095
    [TBL] [Abstract][Full Text] [Related]  

  • 37. On-road assessment of fitness-to-drive in persons with MS with cognitive impairment: A prospective study.
    Morrow SA; Classen S; Monahan M; Danter T; Taylor R; Krasniuk S; Rosehart H; He W
    Mult Scler; 2018 Oct; 24(11):1499-1506. PubMed ID: 28782411
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cognitive impairment in multiple sclerosis].
    Karlińska I; Selmaj K
    Neurol Neurochir Pol; 2005; 39(2):125-33. PubMed ID: 15871058
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cognitive impairment of Japanese multiple sclerosis patients: Follow-up study using BRB-N assessment tool.
    Yoshii F; Takagi S; Nagata E; Hasegawa Y; Kunika N; Maki F; Mochizuki H; Ogino M; Kuroiwa Y
    J Neurol Sci; 2015 Dec; 359(1-2):323-7. PubMed ID: 26671136
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Association between depression and cognitive decline in sclerosis multiplex patients].
    Hegedüs K; Kárpáti J; Szombathelyi É; Simó M
    Neuropsychopharmacol Hung; 2015 Mar; 17(1):31-6. PubMed ID: 25935381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.